 |
|
|
|
|
|
The National AIDS Treatment Advocacy Project - NATAP - provides the latest in HIV and AIDS drug research and treatment information as well as comprehensive reports and developments from the Fifth Retroviruses and Opportunistic Infections conference, as well as from the ICAR, ICAAC, IDSA, European and International HIV and AIDS conferences, and from other sources. |
|
| |
|
|
|
|
|
|
|
|
- HEP DART 2003: Frontiers in drug development for Viral Hepatitis
December 14-18, 2003, Kauai, Hawaii
- NIDA Substance Abuse & HCV Conference
Nov 11-13, 2003, Washington, DC
- 9th European AIDS Conference (EACS)
Oct 25-29, 2003, Warsaw, Poland
- American Association for the Study of Liver Diseases 2003 Conference
Oct 25-29, 2003, Boston, MA
- 43rd ICAAC Meeting
Sept 13-17, 2003, Chicago
- International AIDS Conference
July 13-16, 2003, Paris
- Lipodystrophy Workshop
July 8-11, 2003, Paris
- Immune Reconstitution and Control of HIV Conference
June 2003, Stressa, Italy
- 12th International HIV Drug Resistance Workshop
June 10-14, 2003, Los Cabos, Mexico
- The Digestive Disease Week 2003 Conference
Orlando, Florida May 17-23, 2003
- Report from The 4th International Workshop on Clinical Pharmacology of HIV Therapy
March 27-29, 2003, Cannes, France
Peter L. Anderson, Pharm.D., University of Colorado Health Sciences Center
- 38th Annual Meeting of the European Association for the
Study of the Liver (EASL)
Istanbul, Turkey. March 28-April 1, 2003.
Canceled due to war but NATAP reports key selected abstracts.
- 10th Conference on Retroviruses and Opportunistic Infections
Boston, Mass, Feb 10-14, 2003
|
|
| |
|
|
|
|
